Hepatitis Monthly

Published by: Kowsar

Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard

Yi Xiang Zheng 1 , Shu Juan Ma 2 and Meng Hou Lu 1 , *
Authors Information
1 Viral Hepatitis Key Laboratory of Hunan Province, Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha, China
2 Department of Epidemiology and Health Statistics, School of Public Health, Central South University, Changsha, China
Article information
  • Hepatitis Monthly: February 2016, 16 (2); e31983
  • Published Online: February 16, 2016
  • Article Type: Research Article
  • Received: July 30, 2015
  • Revised: October 19, 2015
  • Accepted: January 6, 2016
  • DOI: 10.5812/hepatmon.31983

To Cite: Zheng Y X, Ma S J, Lu M H. Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard, Hepat Mon. 2016 ;16(2):e31983. doi: 10.5812/hepatmon.31983.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014; 384(9959): 2053-63[DOI][PubMed]
  • 2. Yuen MF, Lai CL. Hepatitis B in 2014: HBV research moves forward--receptors and reactivation. Nat Rev Gastroenterol Hepatol. 2015; 12(2): 70-2[DOI][PubMed]
  • 3. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371(9615): 838-51[DOI][PubMed]
  • 4. van Bommel F, Berg T. Treatment of HBV related cirrhosis. Liver Int. 2013; 33 Suppl 1: 176-81[DOI][PubMed]
  • 5. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383(9930): 1749-61[DOI][PubMed]
  • 6. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57(1): 167-85[DOI][PubMed]
  • 7. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015;
  • 8. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009; 50(1): 36-41[DOI][PubMed]
  • 9. Qu Y, Tan M, Kutner MH. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics. 1996; 52(3): 797-810[PubMed]
  • 10. Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, et al. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol. 2012; 56(3): 541-8[DOI][PubMed]
  • 11. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010; 51(3): 828-35[DOI][PubMed]
  • 12. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2): 518-26[DOI][PubMed]
  • 13. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43(6): 1317-25[DOI][PubMed]
  • 14. Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014; 9(8)[DOI][PubMed]
  • 15. Liu XD, Wu JL, Liang J, Zhang T, Sheng QS. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol. 2012; 18(22): 2784-92[DOI][PubMed]
  • 16. Hadgu A, Qu Y. A biomedical application of latent class models with random effects. J R Stat Soc Ser C-Appl Stat. 1999; 48(3)[DOI]
  • 17. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess. 2007; 11(50)[PubMed]
  • 18. Brito DA, Strauss J, Magidson V, Tikhonenko I, Khodjakov A, Koonce MP. Pushing forces drive the comet-like motility of microtubule arrays in Dictyostelium. Mol Biol Cell. 2005; 16(7): 3334-40[DOI][PubMed]
  • 19. Zhang B, Chen Z, Albert PS. Estimating diagnostic accuracy of raters without a gold standard by exploiting a group of experts. Biometrics. 2012; 68(4): 1294-302[DOI][PubMed]
  • 20. Xu XY, Kong H, Song RX, Zhai YH, Wu XF, Ai WS, et al. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One. 2014; 9(6)[DOI][PubMed]
  • 21. Salkic NN, Cickusic E, Jovanovic P, Denjagic MB, Iljazovic-Topcic S, Bevanda M, et al. Online combination algorithm for non-invasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settings. Eur J Intern Med. 2015; 26(8): 628-34[DOI][PubMed]
  • 22. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97(10): 2614-8[DOI][PubMed]
  • 23. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003; 38(6): 1449-57[DOI][PubMed]
  • 24. Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, Giry C, et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2009; 29(4): 409-15[DOI][PubMed]
  • 25. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46(1): 32-6[DOI][PubMed]
  • 26. Wang H, Xue L, Yan R, Zhou Y, Wang MS, Cheng MJ, et al. Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT. J Viral Hepat. 2013; 20(4)-10[DOI][PubMed]
  • 27. Suh B, Park S, Shin DW, Yun JM, Yang HK, Yu SJ, et al. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology. 2015; 61(4): 1261-8[DOI][PubMed]
  • 28. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015; 61(1): 292-302[DOI][PubMed]
  • 29. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Otaguro S, Hamada M, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007; 37(12): 1002-10[DOI][PubMed]
  • 30. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29(2): 242-7[DOI][PubMed]
  • 31. Sporea I, Sirli R, Deleanu A, Tudora A, Popescu A, Curescu M, et al. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol. 2010; 16(38): 4832-7[PubMed]
  • 32. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010; 53(6): 1013-21[DOI][PubMed]
  • 33. Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, et al. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci. 2011; 56(9): 2742-9[DOI][PubMed]
  • 34. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007; 14(5): 360-9[DOI][PubMed]
  • 35. Wong VW, Lampertico P, de Ledinghen V, Chang PE, Kim SU, Chen Y, et al. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. Dig Dis Sci. 2015; 60(5): 1448-56[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader